Investors should buy the dip on this pharma stock with 40% upside, Truist says
- Posted on May 28, 2025
- By CNBC
- 1 Views
Investors should buy the dip on this pharma stock with 40% upside, Truist says
The firm initiated shares of the drug maker with a buy rating.
